Maryland Oncology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Endometrial cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 11 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Eikon Therapeutics1 trial
• Immuneering Corporation1 trial
• Inspirna, Inc.1 trial

Running trials

• Recruiting

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· Phase 3· Immuneering Corporation· Source

  Contact: Corilynn Hughes

• Active, not recruiting

  A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

  NCT06246110· Phase 2· Eikon Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pancreatic cancer1 recruiting

Closed trials

• Completed

  A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer

  NCT02922764· Phase 1· Inspirna, Inc.· Source